The ANGPTL8 cut-off for predicting DN in the non-NAFLD population was higher than 421.47pg/ml, and the sensitivity and specificity were 65.9% and 62.7% respectively. This evidence concerns the gene ANGPTL8 and liver dysplastic nodule.